Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBlue Cross Blue Shield OK Vitamin B12 Coverage Upd…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - OklahomaPolicy CPCPLABO1O

    Vitamin B12 and Methylmalonic Acid Testing

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Oklahoma Policy CPCPLABO1O alerts

    Get alerted when Policy CPCPLABO1O changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines reimbursement criteria for serum vitamin B12 (cobalamin) and methylmalonic acid testing under Blue Cross Blue Shield - Oklahoma lab management program; affects providers submitting claims for these laboratory tests to BCBSOK members.

    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyVitamin B12 and Methylmalonic Acid Testing
    Policy CodePolicy CPCPLABO1O
    Change TypeMaterial edits to coverage criteria and non-reimbursable tests
    Effective DateApr 15, 2025
    Last ReviewJan 23, 2025
    Next Review Date
    Key ActionSubmit accurate documentation and claims using valid code combinations; claims may be reviewed and additional documentation may be requested.
    SourceLink
    POLICY UPDATE CHANGES

    Added a three month testing frequency limit: total vitamin B12 (serum cobalamin) testing may be reimbursable once every three months.

    Added new #7: total vitamin B12 testing is not reimbursable for all other situations not described.

    Holotranscobalamin (active B12) testing is not reimbursable for screening, testing, or confirmation of vitamin B12 deficiency.

    1x/3mo

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Max reimbursable frequency (total B12)
    >=1Situations listed as potentially reimbursable
    not reimbursableHolotranscobalamin testing
    not reimbursableHomocysteine testing
    reimbursableMethylmalonic acid testing

    Reimbursement Criteria for Vitamin B12 and MMA Testing

    Laboratory reimbursement criteria

    Covered when ALL of the following criteria (and associated limits) are met:

    ANY of the following

    • ALL of the following

      • ALL of the following

        • Hyperpigmentation
        • Jaundice
        • Vitiligo
      • ALL of the following

        • Glossitis
      • ALL of the following

        • Anemia (macrocytic, megaloblastic)
        • Leukopenia
        • Pancytopenia
        • Thrombocytopenia
        • Thrombocytosis
      • ALL of the following

        • Areflexia
        • Cognitive impairment (including dementia-like symptoms and acute psychosis)
        • Gait abnormalities
        • Irritability
        • Loss of proprioception and vibratory sense
        • Olfactory impairment
        • Peripheral neuropathy
    • Individuals undergoing treatment for vitamin B12 deficiency
    • ALL of the following

      • Decreased ileal absorption (e.g., Crohn's disease, ileal resection, tapeworm infection, prior or planned bariatric procedures such as Roux-en-Y, sleeve gastrectomy, biliopancreatic diversion/duodenal switch)
      • Decreased intrinsic factor (e.g., atrophic gastritis, pernicious anemia, postgastrectomy syndrome)
      • Transcobalamin II deficiency
      • Inadequate intake (e.g., alcohol abuse; age >75 years or elderly evaluated for dementia; vegans or strict vegetarians including exclusively breastfed infants of vegetarian/vegan mothers; eating disorders)
      • Prolonged medication use (H2 blockers >12 months; metformin >4 months; proton pump inhibitors >12 months)
    Total vitamin B12 testing reimbursable no more than once every three months for the indications listed above.<= once every 3 months

    ANY of the following

    • May be reimbursable to confirm vitamin B12 deficiency in asymptomatic high-risk individuals with low‑normal serum B12 or when deficiency is suspected but serum B12 is normal or low‑normal
    • May be reimbursable for evaluation of inborn errors of metabolism

    ALL of the following

    • Screening for vitamin B12 deficiency in healthy, asymptomatic individuals
    • Homocysteine testing for confirmation of vitamin B12 deficiency
    • Holotranscobalamin (active B12) testing for screening, testing, or confirmation of vitamin B12 deficiency
    • Total vitamin B12 testing for all other situations not described above

    Example Codes and Frequency Limits

    Example / non-exhaustive codesCPT
    84999Unlisted chemistry procedure (note: policy indicates code was added in revision history but code lists are not exhaustive)
    Example / non-exhaustive codesCPT
    84999Unlisted chemistry procedure (note: policy indicates code was added in revision history but code lists are not exhaustive)
    Testing frequency limit — Total vitamin B12
    Maximum reimbursable frequencyTotal vitamin B12 (serum cobalamin) testing reimbursable once every 3 months
    ScopeApplies to total vitamin B12 testing (serum cobalamin) under BCBSOK lab management reimbursement criteria
    Effective date of changeAdded in policy update effective 01/23/2025 (summary of revisions 04/15/2025)
    Related coding noteProcedure code listing is not all-encompassing; inclusion of a code does not guarantee coverage or reimbursement

    Documentation and Claims Submission Requirements

    Documentation Required

    Documentation and claims submission — submit accurate documentation and valid codes; claims subject to review

    Providers must submit accurate documentation of services performed and submit claims using valid code combinations according to industry-standard coding guidelines. Claims are subject to review, code edit protocols, and may require additional documentation upon request.

    • Use valid code combinations per Uniform Billing Editor, AMA CPT, HCPCS, ICD-10, NDC, DRG, CMS NCCI and CCI guidance.
    • Claims are subject to claim review including benefit coverage, provider contract language, medical and coding policies, and coding software logic.
    • Upon request, providers may be asked to submit additional documentation.

    Plan Documents and Related Terms

    Plan documents (definitions and guidance)
    DefinitionPlan documents include Certificates of Health Care Benefits, benefit booklets, Summary Plan Descriptions, and other coverage documents used by BCBSOK.
    Governing hierarchyIf a conflict exists between this policy and a plan document, the plan document governs; if conflict with a provider contract, the provider contract governs.
    Provider responsibilityProviders are urged to review plan documents for eligible coverage for services rendered.
    DiscretionBCBSOK may use reasonable discretion in interpreting and applying this policy to services in a particular case.
    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyVitamin B12 and Methylmalonic Acid Testing
    Policy CodePolicy CPCPLABO1O
    Change TypeMaterial edits to coverage criteria and non-reimbursable tests
    Effective DateApr 15, 2025
    Last ReviewJan 23, 2025
    Next Review Date
    Key ActionSubmit accurate documentation and claims using valid code combinations; claims may be reviewed and additional documentation may be requested.
    SourceLink
    On This Page
    Reimbursement Criteria for Vitamin B12 and MMA TestingExample Codes and Frequency LimitsDocumentation and Claims Submission RequirementsPlan Documents and Related Terms